Eagle Pharmaceuticals Extends Stockholder Rights Plan Through 2027
Image: TokenPost
The plan’s rights may be triggered at 10% beneficial ownership, or 15% for covered passive institutional investors.
Read the full story on TokenPostBeCrypto News shows a short excerpt and links to the publisher. The full report belongs to TokenPost.
